Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CCKAR Biologics Sequence Review Report 2026: Cholecystokinin receptor type A Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CCKAR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM1 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CALCRL Biologics Sequence Review Report 2026: Calcitonin gene-related peptide type 1 receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CALCRL protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCKBR Biologics Sequence Review Report 2026: Gastrin/cholecystokinin type B receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CCKBR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CADM2 Biologics Sequence Review Report 2026: Cell adhesion molecule 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CADM2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CALCR Biologics Sequence Review Report 2026: Calcitonin receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CALCR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CADM4 Biologics Sequence Review Report 2026: Cell adhesion molecule 4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CADM4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CADM3 Biologics Sequence Review Report 2026: Cell adhesion molecule 3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CADM3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C8G Biologics Sequence Review Report 2026: Complement component C8 gamma chain Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C8G protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C5AR2 Biologics Sequence Review Report 2026: C5a anaphylatoxin chemotactic receptor 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C5AR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CADM1 Biologics Sequence Review Report 2026: Cell adhesion molecule 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CADM1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C5AR1 Biologics Sequence Review Report 2026: C5a anaphylatoxin chemotactic receptor 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C5AR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
51
52
53
54
55
>>
1620
>